InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (1 ops.)
Insider track record
Board DirectorDisclosed buys
0
Disclosed sells
1
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
No signal scores available.
Explore the complete record of transactions filed by Crampton Christopher A.S., Director. Director active across 1 company, notably Sterling Check Corp.. Cumulatively, 1 filings have been published. Breakdown: 0 buy · 1 sell. Total volume traded: €177m. History available since 27 September 2021. The latest transaction was filed on 27 September 2021 (Cession). Regulator: SEC (Form 4). The full history is free.
Companies and markets linked to Crampton Christopher A.S.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations1 total
9,603,419 shares@ US$21.56100.0% of flowCommon StockSEC:0000895345-21-000889:0
1 of 1 declaration
About Crampton Christopher A.S.
David Schaffer is a Board Member at 4D Molecular Therapeutics Inc. He brings expertise in biotechnology and investment strategy to the board. His role involves overseeing growth initiatives and ensuring that operations align with the company's goals.
